IQSEC2

PATRE · IQSEC2 Natural History Study

Every family counts!

Together we are building the largest international collection of data on IQSEC2. Every completed registration brings us closer to better care and future therapies. Please help us get as many families as possible over the finish line!

Every family counts!¡Cada familia cuenta!Jede Familie zählt!Ogni famiglia conta!Chaque famille compte !Każda rodzina się liczy!
Where we stand

A truly international registry

212families registered
33countries
128consent forms complete
63families have completed all core questionnaires
Status: 8 November 2026
Take part

What is your next step?

1

Not registered yet?

Register online with the button below. You will then receive the consent and data protection documents.

Register now
2

Registered, but consent still missing?

Please sign the consent form and upload it. We will send you your personal QR code for the app within one week.

3

Already in the app?

Please complete the 5 core questionnaires: Genetics, Basic Information, Development, Behavior and Epilepsy, step by step on your smartphone.

Questions? Write to us

Where our families come from

RegisteredConsent complete
USA29 / 61Spain18 / 22Italy11 / 22Germany15 / 20France9 / 13Poland8 / 13UK7 / 9Australia3 / 5Argentina2 / 4China4 / 4Colombia2 / 4Romania3 / 4Canada2 / 3Chile2 / 3India2 / 2Ireland2 / 2Mexico2 / 2Israel1 / 2Egypt0 / 2Netherlands0 / 213 more countries6 / 13

Progress in the app

Families in the app who have completed all 5 core questionnaires
English22 / 43 · 51%Español19 / 30 · 63%Deutsch8 / 19 · 42%Italiano6 / 11 · 55%Français4 / 8 · 50%Polski4 / 7 · 57%
84 registered families are still missing a complete consent form, and 55 families in the app still have open questionnaires.
First results

What we have already learned

First baseline results from the PATRE registry (118 registrations, data as of August 2026) will be presented at the American Epilepsy Society meeting (AES 2026) in Denver.

Girls and womenBoys and men
EPILEPSYEpilepsy (ever)62%88%More than 5 seizures per day11%50%DEVELOPMENT & BEHAVIORWalks independently97%35%Uses two-word sentences44%6%Autism-related behaviors often52%47%DAILY LIFEStrong/severe impact of seizures90%64%Severe impact on communication58%71%
Caregiver-reported data; preliminary results, not age-adjusted; percentages based on available answers.

Different for boys and girls

Boys and men more often had epilepsy and very frequent seizures; girls and women more often walked independently and used two-word sentences, as expected for a gene on the X chromosome.

A high burden for all families

Caregivers of both girls and boys rated the impact of seizures and communication difficulties on daily life as substantial.

Why your complete data matter

At the time of the analysis, seizure frequency could only be evaluated for 19 girls and 28 boys. Every completed questionnaire makes the results more reliable and helps prepare future clinical trials.

About the study

PATRE for IQSEC2

What is PATRE?

PATRE (PATient-based phenotyping and evaluation of therapy for Rare Epilepsies) is a natural history study that systematically collects information on people with rare genetic epilepsies. For IQSEC2, families from all over the world take part in six languages, directly from their smartphone.

Who can take part?

People with a genetic diagnosis of IQSEC2, or their parents or legal guardians, from any country.

How are my data protected?

Data are collected via a secure app and stored on a secure server in the EU. Personal data are stored separately from medical data. The study has been approved by an ethics committee (Bavarian State Medical Association).

Download & share

Flyers in six languages

Please share the flyer with families, by email, WhatsApp, in newsletters or on social media.

Study team

Kirsten Eschermann, MD · Lorenz Kiwull, MD
Paracelsus Medical University, Salzburg, Austria
team@patre.info

Paracelsus Medical University
Supported by
IQSEC2 Research and Advocacy Foundation Asociación Española Mutación Gen IQSEC2 AMA.le IQSEC2 APS IQSEC2 Deutschland e.V.